← Open Payments lookup

CHELSEA KAUFFMAN: Open Payments

NPI 1124556832 · LOS ANGELES, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$407 in 21 payments from 9 companies in 2025. Trend: 2023 $372 · 2024 $30 · 2025 $407

Food & beverage: $407
CompanyPaymentsAmount
ABBVIE INC.4$81
Sage Therapeutics, LLC3$69
Bayer Healthcare Pharmaceuticals Inc.2$59
MAYNE PHARMA COMMERCIAL LLC3$52
Exeltis, USA Inc.2$43
Astellas Pharma US Inc1$34
Evofem Biosciences, Inc.4$25
Supernus Pharmaceuticals, Inc.1$23
CooperSurgical, Inc.1$21

Products named: LILETTA, ZURZUVAE, SLYND, Veozah, Mirena, Kyleena, Phexxi, Qelbree.

Industry payments across CA — which companies pay providers there.